Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
As a result of genome-wide association studies in larger sample sets, there has been an increase in identifying genes that influence susceptibility to individual immune-mediated diseases, as well as evidence that some genes are associated with more than one disease. In this study, we tested 17 single nucleotide polymorphisms (SNP) from 16 gene regions that have been reported in several autoimmune diseases including rheumatoid arthritis (RA),
systemic lupus erythematosus
(
SLE
), multiple sclerosis (MS), ankylosing spondylitis (AS) and Crohn's disease (CD) to determine whether the variants are also associated with type 1 diabetes (T1D). In up to 8010 cases and 9733 controls we found some evidence for an association with T1D in the regions containing genes: 2q32/STAT4, 17q21/STAT3, 5p15/ERAP1 (ARTS1), 6q23/
TNFAIP3
and 12q13/KIF5A/PIP4K2C with allelic P-values ranging from 3.70 x 10(-3) to 3.20 x 10(-5). These findings extend our knowledge of susceptibility locus sharing across different autoimmune diseases, and provide convincing evidence that the RA/
SLE
locus 6q23/
TNFAIP3
is a newly identified T1D locus.
...
PMID:Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. 1911 May 36
Systemic lupus erythematosus
(
SLE
) is an autoimmune disease influenced by genetic and environmental factors. We carried out a genome-wide association scan and replication study and found an association between
SLE
and a variant in
TNFAIP3
(rs5029939, meta-analysis P = 2.89 x 10(-12), OR = 2.29). We also found evidence of two independent signals near
TNFAIP3
associated with
SLE
, including one previously associated with rheumatoid arthritis (RA). These results establish that variants near
TNFAIP3
contribute to differential risk of
SLE
and RA.
...
PMID:Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. 1916 18
The
TNFAIP3
(tumor necrosis factor alpha-induced protein 3) gene encodes a ubiquitin editing enzyme, A20, that restricts NF-kappaB-dependent signaling and prevents inflammation. We show that three independent SNPs in the
TNFAIP3
region (rs13192841, rs2230926 and rs6922466) are associated with
systemic lupus erythematosus
(
SLE
) among individuals of European ancestry. These findings provide critical links between A20 and the etiology of
SLE
.
...
PMID:Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. 1916 19
TNFAIP3
encodes the ubiquitin-modifying enzyme, A20, a key regulator of inflammatory signaling pathways. We previously reported association between
TNFAIP3
variants and
systemic lupus erythematosus
(
SLE
). To further localize the risk variant(s), we performed a meta-analysis using genetic data available from two Caucasian case-control datasets (1453 total cases, 3381 total control subjects) and 713
SLE
trio families. The best result was found at rs5029939 (P=1.67 x 10(-14), odds ratio=2.09, 95% confidence interval 1.68-2.60). We then imputed single nucleotide polymorphisms (SNPs) from the CEU Phase II HapMap using genotypes from 431
SLE
cases and 2155 control subjects. Imputation identified 11 SNPs in addition to three observed SNPs, which together, defined a 109 kb
SLE
risk segment surrounding
TNFAIP3
. When evaluating whether the rs5029939 risk allele was associated with
SLE
clinical manifestations, we observed that heterozygous carriers of the
TNFAIP3
risk allele at rs5029939 have a twofold increased risk of developing renal or hematologic manifestations compared to homozygous non-risk subjects. In summary, our study strengthens the genetic evidence that variants in the region of
TNFAIP3
influence risk for
SLE
, particularly in patients with renal and hematologic manifestations, and narrows the risk effect to a 109 kb DNA segment that spans the
TNFAIP3
gene.
...
PMID:Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. 1938 56
In the paper by Dieguez-Gonzalez and colleagues in the present issue of Arthritis Research & Therapy, the results of a detailed genetic investigation of the recently identified rheumatoid arthritis and
systemic lupus erythematosus
susceptibility region at 6q23 containing the
TNFAIP3
gene are reported. Their data confirm the complex nature of the association involving both the
TNFAIP3
locus and a region >150 kb upstream that does not encode any known gene. These data are consistent with recent studies of
systemic lupus erythematosus
susceptibility confirming the presence of several independent genetic contributions to autoimmune rheumatic diseases arising from 6q23.
...
PMID:Complex genetic association of 6q23 with autoimmune rheumatic conditions. 1929 17
Genetic variation was first shown to be important in
systemic lupus erythematosus
(
SLE
or
lupus
) in the 1970s with associations in the human leukocyte antigen region. Almost four decades later, and with the help of increasingly powerful genetic approaches, more than 25 genes are now known to contribute to the mechanisms that predispose individuals to
lupus
. Over half of these loci have been discovered in the past 2 years, underscoring the extraordinary success of genome-wide association approaches in
SLE
. Well-established risk factors include alleles in the major histocompatibility complex region (multiple genes), IRF5, ITGAM, STAT4, BLK, BANK1, PDCD1, PTPN22, TNFSF4,
TNFAIP3
, SPP1, some of the Fcgamma receptors, and deficiencies in several complement components, including C1q, C4 and C2. As reviewed here, many susceptibility genes fall into key pathways that are consistent with previous studies implicating immune complexes, host immune signal transduction and interferon pathways in the pathogenesis of
SLE
. Other loci have no known function or apparent immunological role and have the potential to reveal novel disease mechanisms. Certainly, as our understanding of the genetic etiology of
SLE
continues to mature, important new opportunities will emerge for developing more effective diagnostic and clinical management tools for this complex autoimmune disease.
...
PMID:Recent insights into the genetic basis of systemic lupus erythematosus. 1944 Jan 99
Nuclear factor (NF)-kappaB has an important role in immunity and inappropriate NF-kappaB activity has been linked with many autoimmune and inflammatory diseases. Multiple mechanisms normally ensure the proper termination of NF-kappaB activation. In this context, the intracellular ubiquitin-editing protein A20 (also known as Tumor Necrosis Factor Alpha-Induced Protein 3 or
TNFAIP3
) is a key player in the negative feedback regulation of NF-kappaB signaling in response to multiple stimuli. Moreover, A20 also regulates tumor necrosis factor (TNF)-induced apoptosis. Recent genetic studies demonstrate a clear association between several mutations in the human A20 locus and immunopathologies such as Crohn's disease, rheumatoid arthritis,
systemic lupus erythematosus
, psoriasis and type 1 diabetes. These findings further illustrate the importance of A20 in the resolution of inflammation and the prevention of human disease.
...
PMID:The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. 1964 65
Systemic lupus erythematosus
(
SLE
) is a complex systemic disease influenced by genetic and environmental factors. The exact pathogenesis of
SLE
is still unknown. Recently, several genome-wide association studies (GWA) in European population have found many novel susceptibility genes for
SLE
including
TNFAIP3
. In order to examine whether
TNFAIP3
is associated with
SLE
in Chinese Han population, we genotyped one of its non-synonymous mutation SNP rs2230926, showing significant association evidence with
SLE
in European population, with 1,420 cases and 4,461 controls of Chinese Han by using Sequenom MassArray system. Highly significant association between SNP rs2230926 and
SLE
of Chinese Han was detected [OR = 1.65, 95% confidence interval (CI): 1.392-1.986, P = 2.03 x 10(-8)]. Interestingly, rs2230926 of
TNFAIP3
was also associated with arthritis, ANA and some other subphenotypes of the disease. Our findings suggest that SNP rs2230926 in the
TNFAIP3
might be a common genetic factor for
SLE
within different populations in terms of Chinese Han and European population.
...
PMID:A single-nucleotide polymorphism of the TNFAIP3 gene is associated with systemic lupus erythematosus in Chinese Han population. 1977 92
We performed a genome-wide association study (GWAS) of
systemic lupus erythematosus
(
SLE
) in a Chinese Han population by genotyping 1,047 cases and 1,205 controls using Illumina Human610-Quad BeadChips and replicating 78 SNPs in two additional cohorts (3,152 cases and 7,050 controls). We identified nine new susceptibility loci (ETS1, IKZF1, RASGRP3, SLC15A4, TNIP1, 7q11.23, 10q11.22, 11q23.3 and 16p11.2; 1.77 x 10(-25) < or = P(combined) < or = 2.77 x 10(-8)) and confirmed seven previously reported loci (BLK, IRF5, STAT4,
TNFAIP3
, TNFSF4, 6q21 and 22q11.21; 5.17 x 10(-42) < or = P(combined) < or = 5.18 x 10(-12)). Comparison with previous GWAS findings highlighted the genetic heterogeneity of
SLE
susceptibility between Chinese Han and European populations. This study not only advances our understanding of the genetic basis of
SLE
but also highlights the value of performing GWAS in diverse ancestral populations.
...
PMID:Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. 1983 93
Wegener's granulomatosis (WG), characterized by systemic vasculitis and granulomatous inflammation, is a rare chronic rheumatic condition potentially sharing some etiopathological principles with other autoimmune disorders, e.g., rheumatoid arthritis (RA) and
systemic lupus erythematosus
(
SLE
). Several large association studies have identified genetic risk factors for RA and
SLE
. Thereof, we have evaluated the relevance of the most promising ones in WG. 22 single nucleotide polymorphisms (SNPs) within or in the vicinity of CCL21, CD40, CDK6, IL21, IL2RB, IRF5, KIF5A, KLF12, MMEL1, PRKCQ, STAT4,
TNFAIP3
, and TRAF1/C5 have been genotyped in >600 German WG cases and >800 matched controls. While most polymorphisms did not show suspicious effects on WG susceptibility, SNPs representing
TNFAIP3
(rs6922466, p = 0.032, odds ratio (OR) 0.83, 95% confidence interval (CI) 0.7--0.98) and CDK6 (rs42041, p = 0.0201, OR 1.21, 95% CI 1.03-1.43) revealed nominally significant differences in allele distribution. The strongest association was detected for a functionally relevant four SNP haplotype of IRF5, which comprised a protective effect (p = 0.0000897, p (corrected) = 0.0012, OR 0.73, 95% CI 0.62-0.85) similar to those previously seen in RA and
SLE
. Thus, we suggest that WG,
SLE
, and RA share some, but not many, genetic risk factors, which supports models of partly overlapping etiopathological mechanisms in these disorders.
...
PMID:A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. 2004 10
1
2
3
4
5
Next >>